info@marketresearchfuture.com   📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Articaine Hydrochloride Market Size

ID: MRFR//1902-CR | 156 Pages | Author: Rahul Gotadki| August 2019

Articaine Hydrochloride is gaining popularity worldwide. The expanding number of dental procedures and treatments worldwide may have increased the requirement for efficient local anesthetic.
Dental and medical breakthroughs have enabled new Articaine Hydrochloride forms. These modifications make the medicine more effective, safer, and pleasant for dental patients, growing the market.
More individuals are seeing the dentist because they understand oral health and the need of frequent exams. Articaine Hydrochloride, used in various dental procedures, is in demand as people focus more on preventative care.
As the global population ages, more individuals will require dental care and surgery for oral disorders. Articaine Hydrochloride, a trusted painkiller, is becoming increasingly popular in elderly dental care. This boosts the market.
Market companies are deliberately growing regionally to take advantage of unstudied areas. This increase involves selling Articaine Hydrochloride in emerging nations where people are learning about dental care and obtaining more services.
The strong rivalry amongst Articaine Hydrochloride pharma producers spurs innovation and market expansion. Companies invest in R&D to improve techniques and gain market share.
Government regulations oversee most of the Articaine Hydrochloride market. Government approvals boost healthcare experts' and consumers' faith in firms, helping them enter new markets.
Articaine Hydrochloride is popular since it's cheaper than other local anesthetics. More healthcare personnel are seeking inexpensive, high-quality anesthetics, which is driving Articaine Hydrochloride demand.
Drug businesses and dental care organizations are collaborating to increase Articaine Hydrochloride. These agreements foster collaboration on innovative goods and help corporations gain market share.
Patient preferences for least-invasive and uncomplicated dental treatment determine the sedative used. Articaine hydrochloride is used in dentistry because to its fast onset and short duration. It suits patients' preferences too.

Global Articaine Hydrochloride Market Overview


The articaine hydrochloride market is expected to reach USD 1.38 Billion by 2030 at 8.10% CAGR during the forecast period 2022-2030.


Articaine Hydrochloride Market


Articaine is a form of a local amide anesthetic that is most commonly used in dentistry. The articaine is marketed as a colorless liquid in vials/cartridges (2ml in each vial/cartridge). It is available in two variants, i.e., Articaine-100 & Articaine-200. Articaine-200 is more potent than Articaine-100. The dosage can be based on the type and extent of surgical procedure, depth of anesthesia, degree of muscular relaxation, and condition of the patient. For pediatric patients, dosage based on their age, weight, the physical condition of the patient, and the extent of the surgical procedure.


May 2023: Altamira Therapeutics has announced that the NASAR clinical trial evaluating the effectiveness of Bentrio nasal spray for seasonal allergic rhinitis (SAR) has successfully achieved its primary efficacy goal, which is to measure the change in average reflecting Total Nasal Symptom Score (rTNSS) over a two-week period. The rTNSS exhibited a decrease in the Bentrio group, dropping from an initial score of 6.9 points to an average of 5.0 points over the course of the 14-day treatment period. In the saline spray group, the rTNSS reduced from 6.9 to 6.2 points. Additionally, the NASAR findings indicate that Bentrio demonstrates a statistically significant and clinically significant enhancement in effectiveness compared to the current standard treatment of saline nasal spray. While a saline nasal spray is designed to flush away allergen particles, Bentrio creates a thin protective barrier that prevents these particles from coming into touch with the nasal mucosa. Additionally, it aids in their removal through the natural process of mucociliary clearance. The study recruited 100 patients in Australia and assigned them randomly to two groups. Each group was instructed to use either Bentrio or saline nasal spray three times a day for two weeks or as required.


The articaine hydrochloride industry is growing rapidly. Articaine, with its greater ability to diffuse through tissues, become a very widely used local anesthetic in the European and Canadian markets.


Articaine Hydrochloride Market Trends


Articaine hydrochloride is the most popular local anesthetic for dentistry. For example, in Germany, around 97% of the anesthetic used by dentists is articaine hydrochloride. The growth of the market is likely to be driven by increasing incidences of dental caries and other periodontal diseases, advancement in dental anesthesia delivery system device, increasing the use of articaine for dental surgery, innovative nature of the dental anesthetics industry, and vigorous research and development efforts. 


Periodontal disease is one of the major dental diseases that influence human populations worldwide at high prevalence rates. Periodontal diseases are more prevalent in Asia-Pacific. Lack of the most basic oral health education and limited availability of simple interventions like pain relief and emergency care for acute infection and trauma to the vast majority of the population, especially in the rural areas are major reasons for the high incidences of periodontal diseases in the region. According to the FDI World Dental Federation, more than 80% of people in Asia-Pacific, including countries such as India, Bangladesh, Nepal, Malaysia, and Indonesia, suffer from dental decay. Furthermore, 40–59% of the population in China and Australia suffer from dental caries.


Some of the popular local anesthesia other than articaine are prilocaine, lidocaine, mepivacaine, and bupivacaine. The availability and usage of alternative products are likely to thwart the growth of the articaine hydrochloride market during the forecast period.


Articaine Hydrochloride Market Segment Insights


The articaine hydrochloride market has been segmented into application and end user.  


Articaine Hydrochloride Application Insights


Based on application, the global market has been segmented into infiltration, nerve block, and others. 


Articaine Hydrochloride End User Insights


Based on end-user, the global market has been segmented into dental clinics, hospitals, and academics & research institutes. The dental clinics segment accounted for a market value of USD 798.5 million in 2018.


Articaine Hydrochloride Regional Insights


The articaine hydrochloride market, based on region, is segmented into Europe, North America, Asia-Pacific, and the Middle East and Africa. The articaine hydrochloride market in Europe is the largest region in the market and is expected to develop continuously due to the increasing demand and focus on dental treatments. The growing awareness of preventative and corrective treatment in European countries is also one of the factors driving the growth of this market. The articaine hydrochloride market in Europe is mainly focusing on a new style of management system that would engage dental specialists to run more effective practices and permit them to concentrate on better clinical care.


North America accounted for the second-largest share in the articaine hydrochloride market. The increasing acceptance of the articaine by dental professionals is one of the factors for the growth of the articaine hydrochloride market in this region.


Asia-Pacific is one of the fastest-growing markets for articaine hydrochloride. Although Australia is dominating the Asia-Pacific market with high adoption of new technology and its usage of dental applications, China, Japan, and India are the countries mainly responsible for the exponential growth of the articaine hydrochloride market in Asia-Pacific. The demand for articaine hydrochloride in India offers several growth opportunities owing to the rising awareness of new applications. In Asia-Pacific, India accounted for a market share of 8.5% in 2018.


Articaine Hydrochloride Market Top Key Players


The prominent players in the articaine hydrochloride market are 



  • 3M (US)

  • Anhui BBCA Pharmaceutical Co., Ltd. (China)

  • Dentsply Sirona (US)

  • Inibsa Dental S.L.U (Spain)

  • Jinan Chenghui Shuangda Chemical Co., Ltd. (China)

  • Jinan Ruixing Pharmaceutical Technology Co., Ltd (China)

  • Manus Aktteva Biopharma LLP (India)

  • Pfizer Inc. (US)

  • Pierrel S.p.A (Italy)

  • Sanofi (France)

  • Septodont (France)

  • Siegfried AG (Switzerland)

  • Sigma Aldrich (US)


 


Some of the key strategies followed by the players operating in the articaine hydrochloride market were innovation, product development, acquisition, and expansion.


Key Updates



  • In March 2018, Dentsply Sirona Inc. announced the signing of a definitive agreement to acquire OraMetrix. Thus, the company aims to expand its product portfolio in the market.



  • In June 2016, Pierrel S.p.A. entered into a ten-year agreement with Safco Dental Supply Co. for the production and marketing of the anesthetic articaine in the US.



  • In June 2016, Septodont acquired the injectable dental anesthetic manufacturing plant from Dentsply International, located in Brazil.


Articaine Hydrochloride Market Segmentation


Articaine Hydrochloride Application Outlook



  • Infiltration

  • Nerve Block

  • Others


Articaine Hydrochloride End User Outlook



  • Dental Clinics

  • Hospitals

  • Academics & Research Institutes


Articaine Hydrochloride Regional Outlook



  • Europe

    • Western Europe

      • Germany

      • UK

      • France

      • Italy

      • Spain

      • Rest of Western Europe



    • Eastern Europe





  • North America

    • US

    • Canada





  • Asia-Pacific

    • Australia

    • Japan

    • China

    • India

    • Rest of Asia-Pacific





  • Middle East & Africa

    • Middle East

    • Africa




Available Additional Customizations



  • Additional Companies

    • Transo-Pharm Handels GmbH

    • Orgapharm

    • Axyntis

    • Benechim s.p.r.l.

    • Green Stone Swiss Co., Ltd

    • Moehs Iberica SL





  • Supply & Demand Analysis

  • Investment Opportunities and Mega Trends in the market


Intended Audience



  • Drug manufacturers and distributors

  • Government research organizations

  • Hospitals and clinics

  • Regulatory agencies

  • Pharmaceutical companies

  • Anesthetic compounds manufacturers

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.